• AAPL 194.15
  • TSLA 241.93
  • AMZN 146.62
  • BTC-USD 43263.1016
  • ETH-USD 2344.375
  • EURUSD 1.0795
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. VOR.US

Vor Biopharma Inc (VOR NASDAQ) stock market data APIs

$2.29 0.08(3.6%) as of December 6, 2023

Vor Biopharma Inc Financial Data Overview

2.21
2.29
-
2.35
2.17
1.62-7.57
150 M
67 806 K
0
-0.49
0
-0.561
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'VOR',
Type: 'Common Stock',
Name: 'Vor Biopharma Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00NBJRDT6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1817229',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-02-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
GicSector: 'Health Care',
GicGroup: 'Pharmaceuticals, Biotechnology & Life Sciences',
GicIndustry: 'Biotechnology',
GicSubIndustry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Vor Biopharma Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -119 405 000
  • Earnings Per Share -1.89
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Vor Biopharma Inc Earnings via APIs

  • Latest Release 2023-11-07
  • EPS/Forecast -0.47

Get Vor Biopharma Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Vor Biopharma Inc latest news via APIs

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Biopharma CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of November 29, 2023 ...

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host ...
  • CALENDAR OF EVENTS
  • NASDAQ:VOR
  • VOR BIOPHARMA
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com